Dysphonia may arise even at comparatively low dosages. Postmenopausal Females acquiring 50 mg nandrolone decanoate each and every four weeks for any year, superimposed on hormonal substitute therapy (HRT; two mg estradiol daily), documented additional voice problems than those acquiring HRT only (220). Objectively, there was a loss of high frequenc